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1. Introduction  
Coronary artery disease (CAD) is the leading cause of death in United States and contributes 
to significant mortality around the world. According to the Heart Disease and Stroke 2011 
update, released by the American Heart Association, 82,600,000 American adults (>1 in 3) 
have 1 or more type of cardiovascular disease and >2200 Americans die of CAD every day 
which is an average of 1 in every 39 seconds. These are alarming statistics and underscore 
the importance of continued understanding of the processes involved in the development of 
CAD. Atherosclerosis, characterized by increased lipid accumulation in the artery wall, is 
the major underlying cause of CAD.  
Atherosclerosis is a chronic disease that often starts during early teens and progresses 
silently without any overt clinical symptoms till about age 40 when it manifests as heart 
attack or even stroke. While it is well established that accumulation of lipid-laden 
macrophage foam cells in the artery wall is the hall mark of atherosclerosis, two different 
theories are proposed to describe the events leading to infiltration of macrophages and 
subsequent development of foam cells within the artery wall. According to “response to 
injury” hypothesis, the initiating event is injury to the endothelial lining of the artery wall 
leading to the subsequent migration of monocytes and circulating lipoproteins mainly the 
low density lipoprotein (LDL) into the intimal space. This is followed by the unregulated 
uptake of modified LDL (mLDL) by monocyte derived macrophages leading to the 
formation of foam cells (Ross et al, 1977, Ross, 1993). “Response to retention” hypothesis, on 
the other hand, proposes that LDL migrates into the intimal space and is retained by 
association with the proteoglycans and is modified. Subsequent uptake by infiltrating 
macrophages results in development of foam cells (Williams and Tabas, 1995). Regardless of 
the sequence of events, the end result is accumulation of foam cells in the intimal space of 
the artery wall. This initiates the formation of fatty streaks which develops into an 
atherosclerotic plaque with continued accretion of foam cells. Figure 1 below summarizes 
these major events that lead to the formation of atherosclerotic plaque. 
Continuous accumulation of lipid laden foam cells in an atherosclerotic plaque not only 
contributes to its volume but also enhances plaque associated inflammation and thus 
determines its vulnerability to rupture (Davies and Thomas, 1985). Therefore, reduction in 
the lipid core of the plaque is an obvious strategy to target reduction in plaque volume as 
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well as enhance plaque stability. However, no therapies are currently available to reduce the 
lipid burden of atherosclerotic plaque. The presently used therapies for CAD include 
cholesterol lowering drugs such as statins that reduce plasma cholesterol by inhibiting the 
endogenous cholesterol synthesis. As a consequence, there is reduction in plasma LDL 
cholesterol levels which limits further foam cell formation and progression of atherosclerotic 
plaque. Nonetheless, these cholesterol lowering drugs do not increase removal of lipid from 
existing plaques and, therefore, cannot achieve plaque regression. Cleveland Clinic study by 
Nissen et al (Nissen et al, 2003) provided the first direct evidence of the clinical benefit of 
enhancing removal of cholesterol from macrophage foam cells. A detailed understanding of 
the cellular mechanisms that regulate lipid accumulation within macrophage foam cells and 
processes that are critical for mobilization of stored lipid is central to future development of 
targeted strategies to reduce atherosclerotic plaque burden with the aim to reduce CAD. 
 
 
CE: Cholesteryl esters; M: macrophage; mLDL: modified LDL 
Fig. 1. Schematic showing the events in the artery wall that lead to the formation of 
atherosclerotic plaque 
2. Macrophage cholesterol homeostasis 
Cholesterol homeostasis in macrophages and other peripheral cells is maintained by a 
balance between the influx and efflux processes. Cholesterol influx occurs by receptor and 
non-receptor mediated uptake of both normal and modified lipoproteins. The uptake of 
native LDL via the LDL receptor is regulated by the feedback inhibition of LDL receptor 
expression by cellular cholesterol levels and most peripheral cells limit their cholesterol 
uptake by this mechanism. Excess LDL returns to the liver where it is, once again, taken up 
via LDL receptor. Under conditions of increased dietary intake or increased endogenous 
synthesis of cholesterol, circulating LDL that cannot be taken by peripheral tissues or liver 
due to the inhibition of the expression of LDL receptor, becomes modified and is no longer 
a ligand for LDL receptor. Macrophages play a critical role in the removal of this modified 
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LDL. Macrophages express scavenger receptors, namely, scavenger receptor A (SR-A) and 
CD-36, that facilitate the uptake of modified LDL. Scavenger-receptor mediated uptake of 
modified LDL is largely unregulated and should be regarded as a mechanism that evolved 
to effectively clear modified lipoproteins from circulation and thus preventing the 
associated toxicity. Non-receptor mediated uptake pathways have recently been identified 
such as phagocytosis of aggregated LDL and macropinocytosis of native LDL that can also 
potentially contribute to lipid accumulation in macrophage foam cells. Cholesteryl esters 
(CE) associated with LDL are hydrolyzed in late endosomes/ lysosomes to free cholesterol 
(FC) which then traffics to and integrates into the plasma membrane. Excess membrane 
cholesterol and also a fraction of LDL-derived FC is transported to endoplasmic reticulum 
where it is re-esterified by acyl CoA:cholesterol acyltransferase-1 (ACAT1) and stored in 
cytoplasmic lipid droplets. While this re-esterification of cholesterol is initially beneficial to 
the cells in preventing the FC-associated cell toxicity, under conditions of unregulated or 
increased uptake of modified LDL, it leads to excessive accumulation of CE present as 
cytoplasmic lipid droplets giving the cells their characteristic “foamy” appearance. Cellular 
CE undergo constant cycle of hydrolysis and re-esterification (cholesteryl ester cycle) with 
a half life of 24h. Brown et al demonstrated for the first time that hydrolysis of stored CE is 
extra lysosomal and defined the “need” for a neutral cholesteryl ester hydrolase (CEH) 
(Brown et al, 1980) that can release FC from the lipid droplet associated CE which can 
either be re-esterified again by ACAT-1 or removed from the cells by extracellular 
acceptor-mediated cholesterol efflux. This acceptor mediated FC efflux is the major 
mechanism for the removal of cellular cholesterol. Efflux of FC occurs either by aqueous 
diffusion or via several transporters namely ATP binding cassette transporter A1 (ABCA1) 
and ABCG1. Bidirectional flux of FC also occurs through scavenger receptor BI (SR-BI). 
Since FC is extremely hydrophobic, its efflux from the cells is coupled to its association 
with specific extracellular acceptors. Macrophages secrete apolipoprotein E (ApoE) and it 
is believed that ApoE serves as the extracellular acceptor for FC that is effluxed via 
aqueous diffusion pathway. Serum albumin, present in the interstitial fluid, also serves as 
an important acceptor for FC effluxed via non-transporter mediated pathways. 
Apolipoprotein A1 that is synthesized in the liver and secreted as minimally lipidated 
particle containing small amount of phospholipids is the acceptor for FC effluxed via 
ABCA1. After acquiring some amount of FC, ApoA1 can no longer accept FC from ABCA1. 
Bulk of FC efflux occurs via ABCG1 and ApoA1 with some FC or high density lipoprotein 
(HDL) serve as the extracellular acceptor for this process. A small amount of FC is also 
converted into 27-hydroxycholesterol which can readily diffuse out of the cell and 
contribution of this pathway towards total FC removal from macrophages remains 
undefined. Figure 2 summarizes the various influx and efflux pathways involved in 
macrophage cholesterol homeostasis. Under normal physiological conditions a balance 
between these influx and efflux pathways maintains the levels of cellular cholesterol in 
macrophages and prevents foam cell formation. However, an imbalance between influx 
and efflux, occurring by either increased influx (under conditions with high levels of 
circulating LDL such as hypercholesterolemia) or decreased efflux (under conditions of 
aberrant cellular processes reducing FC availability for efflux or decreased levels of 
extracellular FC acceptors), cellular accumulation of CE containing lipid droplets increases 
resulting in the formation of foam cells and initiating atherogenesis. Improved 
understanding of these processes is, therefore, critical to developing new strategies to not 
only prevent foam cell formation but also to reduce CE burden of existing foam cells that 
may be associated with atherosclerotic lesions.  
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ABC: ATP binding cassette transporter; ACAT: Acyl-CoA cholesterol acyltransferase; ACEH: Acid 
cholesteryl ester hydrolase; ApoE: Apolipoprtoein E; CE: Cholesteryl ester; CEH: Cholesteryl ester 
hydrolase; FC: Free cholesterol; LDLR: LDL receptor; mLDL: Modified LDL; PL: Phospholipids; SR-A: 
Scavenger receptor type A; SR-BI: Scavenger receptor class B type I. 
Fig. 2. Macrophage Cholesterol Homeostasis: Influx and Efflux Pathways 
2.1 Cholesteryl ester accumulation  
Cellular CEs exist in dynamic equilibrium with FC in a futile cholesteryl ester cycle with a half 
life of 24h. The two enzymes involved in this cycle are Acyl-CoA cholesterol acyltransferase 
(ACAT) and cholesteryl ester hydrolase (CEH). Two distinct genes have been identified for 
ACAT; ACAT1 is ubiquitously expressed in all cell types including macrophages and ACAT2 
expression is restricted to liver and intestine. Since foam cells are characterized by 
accumulation of CE and ACAT1 is responsible for formation of CE, pharmacological inhibition 
of ACAT was initially pursued as a means to prevent or attenuate foam cell formation 
(Matsuda, 1994, Matsuo et al, 1995, Nicolosi et al, 1998, Sliskovic and White, 1991). However, 
increased plaque formation by preferential pharmacological inhibition of ACAT-1 was noted 
in mouse and rabbit models of atherosclerosis (Perrey et al, 2001). Ablation of ACAT1 gene 
resulted in marked systemic abnormalities in lipid homeostasis in hyper-cholesterolemic Apo-
E deficient and LDL-receptor deficient mice, leading to extensive deposition of free cholesterol 
in skin and brain (Accad et al, 2000, Yagu et al, 2000). Further, ACAT1-deficient mice also 
displayed an increase in lesion area and the systemic lipid abnormalities. Inhibition or 
deficiency of ACAT1 also results in increased intracellular FC since it cannot be esterified to 
CE which is its inert and storage form. A rise in FC above its physiological concentration is 
associated with cellular toxicity (Glass and Witztum, 2001). Enrichment of the endoplasmic 
reticulum (ER) with FC induces ER stress leading to apoptosis. Therefore, although intuitively 
a logical strategy to limit cellular CE accumulation, inhibition or deficiency of ACAT1 has 
detrimental effects.  
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Alternatively, reduction in CEs stored in macrophage foam cells can also be achieved by 
enhancing mobilization. The first and the rate limiting step in cellular CE mobilization is CEH-
mediated hydrolysis. Consistently, macrophages with high neutral CEH activity accumulate 
less cholesterol esters in the presence of atherogenic -migrating very low-density lipoproteins 
(-VLDL) in comparison to macrophages with low CEH activity (Ishii et al, 1992). Further, 
animal models of atherosclerosis, such as the hypercholesterolemic rabbit and the white 
Carneau pigeon, appear to possess macrophages in which stored cholesterol esters are 
resistant to hydrolysis and subsequent mobilization (Mathur et al, 1985, Yancey and St. Clair, 
1994). While increased hydrolysis of CE will also lead to increase in FC but there is a 
fundamental difference between CEH activation and ACAT1 inhibition. Under conditions of 
ACAT1 inhibition, cellular FC has only one fate, namely, efflux to extracellular acceptors. 
However, FC generated as a result of CEH activation can either be re-esterified by ACAT1 or 
be effluxed to extracellular acceptor (two fates). Thus, CEH activation or over-expression does 
not result in an increase in cellular FC and is not associated with toxicity seen with ACAT1 
inhibition indicating that CEH-mediated increase in cellular CE mobilization is a valid 
approach to target attenuation of foam cell formation (Ghosh et al, 2009). 
2.2 Cholesteryl ester hydrolysis and cellular CE mobilization 
Unregulated uptake of modified lipoproteins by macrophages can be regarded as a defence 
mechanism by which removal of these potentially toxic particles is facilitated. As discussed 
above, efflux of FC from macrophage foam cells is the major mechanism by which this CE 
accumulation can be reversed underscoring the importance of intracellular CE hydrolysis. 
Since the first description for the “need” of an extra lysosomal neutral CEH, several 
candidate enzymes have been identified as potential CE hydrolases in macrophages. Based 
on the observations that cAMP enhances FC efflux from macrophages and hormone 
sensitive lipase (HSL), an enzyme initially characterized from adipose tissue, requires 
protein kinase A and cAMP dependent activation, HSL was thought to be the likely 
candidate for macrophage CE hydrolysis (Goldberg and Khoo, 1990, Small et al, 1989). HSL 
is expressed in murine macrophages (Khoo et al, 1993) but its expression in human 
macrophages remains controversial (Johnson et al, 2000, Li and Hui, 1997, Reue et al 1997). 
Over-expression of HSL by transient transfection in murine macrophages led to increased 
mobilization of CE in the presence of an ACAT inhibitor (Escary et al 1998) but macrophage-
specific transgenic expression of HSL led to a paradoxical increase in atherosclerosis and 
macrophages isolated from these mice stored 2-3 fold higher CE when incubated with 
AcLDL in vitro (Escary et al 1999). In addition, macrophages from HSL deficient mice did 
not have reduced CE mobilization suggestive of a limited, if any, role of HSL in macrophage 
CE mobilization. Since the effects of HSL deficiency on atherosclerosis have not been 
studied, it remains to be seen whether HSL plays a role in atherogenesis. 
The second candidate enzyme speculated to play a role in macrophage CE mobilization was 
carboxyl ester lipase or CEL. CEL was first characterized from pancreas as a bile salt 
dependent cholesteryl esterase (Gallo, 1981, Kissel et al, 1989) that was also present in other 
tissues and was secreted in milk to facilitate digestion of CE in infants and newborns (Hui and 
Kissel, 1990). Li and Hui demonstrated the presence of CEL in human monocyte/macrophage 
cell line THP1 as well as primary blood derived monocyte macrophages and reported the 
absence of HSL in these cells (Li and Hui, 1997). However, since CEL is a secretory enzyme 
and it was thought to play a limited role in intracellular CE metabolism.  
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Pursuing the characterization of neutral CEH, we purified and cloned rat liver neutral 
cytosolic CEH which belonged to the carboxylesterase family and was distinctly different 
from HSL and CEL although it shared the same catalytic triad (Ghosh and Grogan, 1991, 
Ghosh et al, 1995). Using the strategy of homology cloning, we subsequently identified 
human macrophage CEH (Official gene symbol CES1, Accession number NG_012057) and 
demonstrated its expression in the THP1 human monocyte/macrophage cell line, as well as 
in human peripheral blood monocyte/macrophages (Ghosh, 2000). This enzyme associated 
with the surface of lipid droplets in lipid-laden cells (its physiological substrate) and 
hydrolyzed CE present in lipid droplets (Zhao et al, 2005). Over-expression of this enzyme 
resulted in mobilization of cellular CE (Ghosh et al, 2003) demonstrating its role in 
regulating cellular CE accumulation. Stable over-expression of this CEH in human 
monocyte/macrophage cell line, THP1, resulted in significantly higher FC efflux to ApoAI, 
HDL and serum demonstrating that FC released by CEH-mediated hydrolysis of 
intracellular CE is available for efflux by all known pathways (Zhao et al, 2007). Taken 
together, these data support the role of this enzyme in regulating macrophage CE content 
and FC efflux. 
Stating the inability to measure CE hydrolytic activity associated with human CEH and its 
murine orthologue triglyceride lipase (TGL), Okazaki et al used a proteomics approach to 
identify another enzyme containing lipase consensus motifs and /-hydrolase folds and 
reported the characterization of murine orthologue of AADACL1 (a deacetylase) also 
known as KIAA1363 (Okazaki et al, 2008). While its deficiency significantly reduced the 
deacetylase activity it did not affect CE hydrolase activity (Buchebner et al, 2010). These 
authors also found no difference in lipid droplet formation and cellular CE and FC content 
of HSL-deficient macrophages. Based on the data obtained with HSL and AADACL1 or 
KIAA1363 deficient macrophages, it can be concluded that macrophage CE hydrolysis is 
likely a multi-enzyme process. Considering the importance of CE hydrolysis in cellular CE 
mobilization, natural redundancy in enzymes capable of catalyzing this reaction is probably 
a protective mechanism evolved to prevent pathological consequences of lipid 
accumulation. 
2.3 CEH and atherogenesis 
Despite the apparent uncertainty surrounding the identity of macrophage CE hydrolase, 
the importance of this step in mobilization of CE and thereby attenuating atherosclerosis 
cannot be over-emphasized. The hypothesis that enhancing CE hydrolysis will reduce 
foam cell formation and consequently attenuate atherogenesis, was initially tested by 
development of HSL transgenic mice (Escary et al, 1999). Paradoxically, these mice had 
increased atherosclerosis and it was thought to be due to limiting levels of extra cellular 
acceptors. Subsequently, Choy et al developed ApoA IV and HSL double transgenics in 
C57BL/6 background and demonstrated a decrease in diet-induced atherosclerosis 
compared to HSL transgenics (Choy et al, 2003). HSL deficiency, however, did not have 
any effect on macrophage CE hydrolytic activity (Osuga et al, 2000) precluding its role in 
macrophage cholesterol homeostasis (Contreras, 2002) and no studies have been 
performed to date to directly assess the development of atherosclerosis in HSL deficient 
mice. 
Since CEL expression was demonstrated in human macrophages, Kodvawala et al 
developed macrophage-specific CEL transgenic mice to evaluate the role of this CE 
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hydrolase in the development of atherosclerosis (Kodvawala et al, 2005). In athero-
susceptible ApoE-/- background, CEL transgenic mice displayed an approximate 4-fold 
higher atherosclerotic lesion area than ApoE(-/-) mice without the CEL transgene. It was 
speculated that perhaps its extracellular location or its hydrolysis of ceramide and 
lysophosphatidylcholine leads to increased cholesterol esterification and decreased 
cholesterol efflux resulting in increased atherosclerosis. Regardless of the underlying 
mechanisms, these studies demonstrate a minimal role for CEL in macrophage CE 
mobilization and thereby in atherogenesis. 
To evaluate the role of CEH in foam cell formation and atherogenesis, we developed 
macrophage-specific CEH transgenic mice and crossed them into an atherosusceptible 
LDLR-/- background. High-fat high-cholesterol diet induced atherosclerosis was 
evaluated and we reported almost a 50% reduction in lesion area in LDLR-/-CEH 
transgenic mice compared to LDLR-/- mice (Zhao et al, 2007). In addition, CEH-mediated 
increase in CE mobilization also reduced total cholesterol and CE content of the lesions 
resulting in significantly reduced lesion necrosis. Consistent with our in vitro studies, 
macrophages from CEH transgenic mice showed higher FC efflux and decreased cellular 
CE levels upon loading with modified LDL. Over-expression of CEH in macrophages 
alone increased the process of reverse cholesterol transport and there was increased 
elimination of cholesterol in the feces of CEH transgenic mice (Zhao et al, 2007). The 
success in attenuating atherosclerosis and lesion necrosis by transgenic expression of CEH 
underscores the importance of the role of CE hydrolysis in atherogenesis. Transgenic mice 
over-expressing the newly identified CE hydrolase (AADACL1 or KIAA1363) have not 
yet been developed and the role of this enzyme in affecting atherogenesis remains to be 
evaluated.  
2.4 CEH and elimination of cholesterol from the body 
While hydrolysis of CE stored in macrophage represents the first step towards removal of 
FC from lesion associated foam cells, final removal of FC occurs from the liver either via 
direct secretion into bile or by conversion into bile acids, both of which are excreted in the 
feces. Figure 3 below summarizes the different steps involved in the movement of FC from 
macrophages to liver for final elimination, a process called Reverse Cholesterol Transport. 
FC effluxed from macrophages becomes associated with extracellular cholesterol acceptors 
and apolipoprotein A1 (ApoA1) is the major acceptor. Lipid free ApoA1 accepts FC 
transported via ABCA1 and this partially lipidated ApoA1 or nascent HDL (High density 
lipoprotein) then becomes the acceptor of FC transported via ABCG1. Bulk of FC efflux to 
HDL occurs via ABCG1 although bidirectional flux of FC also occurs through SR-BI. In the 
plasma compartment, FC in HDL particle is esterified by plasma Lecithin cholesterol 
acyltransferase (LCAT) and CE constitutes greater than 80% of total cholesterol carried by 
the HDL particle. In the liver, HDL binds to its receptor SR-BI and delivers its lipid “cargo”, 
and lipid poor HDL is presumed to return into circulation to further serve as the 
extracellular cholesterol acceptor and facilitate removal of cholesterol from peripheral 
tissues including artery wall associated macrophage foam cells. This function of HDL is 
responsible for its alias “Good cholesterol” in contrast to LDL or “Bad cholesterol” that 
delivers cholesterol to the peripheral tissues and is responsible for CE accumulation in 
macrophages.  
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Fig. 3. Reverse Cholesterol Transport 
FC delivered to the liver via SR-BI is believed to be directly secreted into bile (Kozarsky et 
al, 1997). On the other hand, for generation of FC, the HDL-delivered CE, once again, needs 
to be hydrolyzed underscoring the importance of CEH in hepatic CE metabolism. FC enters 
the hepatic metabolic pool where it is either re-esterified by ACAT2 (distinct from ACAT1 
present in macrophages) or secreted into bile or converted into bile acids where the rate-
limiting step is catalyzed by cholesterol 7 hydroxylase (C7H). It should be emphasized 
that although humans and other mammals can synthesize cholesterol starting from acetate, 
they lack the enzymes required to degrade the steroid nucleus. Extremely hydrophobic 
cholesterol requires several modifications to increase its water solubility and to facilitate its 
excretion. Conversion of cholesterol to water soluble bile acids is one such mechanism 
which along with direct secretion of cholesterol in bile represents the major route of 
cholesterol elimination from the body.  
2.4.1 Hepatic CE hydrolysis 
Based on immunological cross reactivity and observed variations in CE hydrolytic activities 
in rat liver, Harrison speculated that hepatic CE hydrolytic activity is due to the uptake of 
pancreatic cholesterol esterase and that liver does not synthesize a similar enzyme 
(Harrison, 1988). This concept gained further support by the observed similarity between 
pancreatic and liver enzymes (Camulli, 1989, Chen 1997). However, we purified and 
characterized a rat hepatic CEH that was immunologically distinct from pancreatic CEH 
(Ghosh 1991). Molecular cloning of this rat liver CEH identified it as a member of the 
carboxylesterase family of enzymes (Ghosh et al., 1995). Biochemical, physiological and 
developmental characterization of this enzyme confirmed its role in regulating hepatic 
cholesterol homeostasis (Natarajan et al, 1996, 1998, Ghosh et al 1998). Homology cloning, 
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based on this rat liver CEH, was used to identify the human macrophage CEH described 
above (Ghosh 2000). We also cloned CEH from human liver and demonstrated that, unlike 
ACAT, hepatic and macrophage CEH are products of the same gene Ces1 (Zhao et al., 2005).  
To evaluate the role of hepatic CEH in regulating hepatic cholesterol metabolism, we over 
expressed CEH in mouse liver using adenovirus. Our data demonstrated a significant 
increase in bile acid secretion following adenovirus-mediated over-expression suggesting 
that CEH plays an important role in regulating this last step of RCT and enhances the 
elimination of cholesterol from the body (Zhao et al, 2008). To address the question whether 
enhancing CEH mediated CE hydrolysis in liver can increase in vivo RCT, we utilized 
“macrophage-to-feces” in vivo RCT model described by Zhang et al (Zhang et al, 2003). 
Adenovirus mediated over-expression of CEH led to a significant increase in the flux of 
cholesterol from macrophages to feces, predominantly in fecal bile acids (Zhao et al, 2008). 
These data demonstrate that increase in hepatic CEH alone can increase the flux of 
cholesterol from peripheral tissues such as macrophages to liver and ultimate elimination 
from the body into feces. Such enhanced elimination of cholesterol from the body should be 
potentially anti-atherogenic and to test the hypothesis that increase in hepatic CEH alone 
can reduce atherosclerosis, we have developed liver-specific CEH transgenic mice and 
studies are in progress to evaluate the effects on diet-induced atherosclerosis in these 
transgenic mice in an LDLR-/- background.  
Initially HSL was thought be not expressed in liver (Holm et al, 1987), but re-evaluation of 
HSL-/- mice has provided some evidence that suggests that HSL might be expressed in liver 
and may contribute to CE hydrolysis in hepatocytes (Sekiya et al 2008, Fernandez et al 2008). 
However, to date, there are no reports of direct evaluation of HSL in regulating bile acid 
synthesis precluding the determination of its role in RCT and cholesterol elimination from 
the body. Expression of AADLAC1 or KIAA1363 is negligible in human and mouse liver 
and it is unlikely to play a significant role in either hepatic cholesterol homeostasis or in 
regulating the terminal step of RCT, namely hydrolysis of HDL-delivered CE.  
2.5 Metabolic consequence of CE accumulation in macrophages 
Intracellular accumulation of CE or cholesterol is considered to enhance the expression of 
pro-inflammatory mediators. Fazio and Linton proposed a feedback loop linking 
macrophage cholesterol balance and inflammatory mediators and suggested that a 
primary defect in cellular cholesterol balance may induce changes in the inflammatory 
status of the macrophage (Fazio and Linton 2001). Close relationship between 
macrophage cholesterol efflux and inflammation is also exemplified by attenuation of in 
vitro efflux and in vivo RCT by endotoxins (McGillicuddy et al 2009). In addition, pro-
inflammatory cytokines such as IL-1 and TNF enhance lipid accumulation and foam 
cell formation by reducing lipid catabolism (Persson et al 2008). Consistently, under 
conditions of enhanced cholesterol accumulation, for example by deficiency of cholesterol 
transporter ABCA1, there was a marked increase in TNF- secretion from macrophages 
(Koseki et al 2007) and increased inflammation with resulting loss in pancreatic beta cell 
function (Tang and Oram, 2009). It is also noteworthy that macrophages from ldlr-/-
Abca1-/- mice with 80-fold increase in cellular CE content display an exaggerated 
inflammatory response (Francone et al, 2005). Thus, accumulation of CE in macrophages 
is likely to be central to the development of multiple metabolic disorders including 
atherogenesis, diabetes and hepatic steatosis (Figure 4).  
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Fig. 4. Role of macrophage foam cell in regulating multiple metabolic disorders 
2.5.1 CEH-mediated CE mobilization and inflammation 
In contrast to CE accumulation, over-expression of ApoA1 that enhances CE removal and 
decreases cellular cholesterol levels results in attenuated response to pro-inflammatory 
insult by LPS (Levine et al 1993). Further, a recent clinical study demonstrated beneficial 
effects of re-constituted HDL infusions that enhance cholesterol efflux from cells on 
suppression of inflammation (Patel et al 2009) underscoring the importance of cholesterol 
removal in modulating inflammatory processes.  
The observed decrease in lesion necrosis in CEH transgenic mice (Zhao et al 2007) was the 
first indication that CEH-mediated increase in macrophage CE mobilization is likely to be 
anti-inflammatory. We, therefore, directly examined the effects of CEH mediated hydrolysis 
of intracellular CE on reducing inflammation and inflammation-linked pathologies. 
Macrophage-specific transgenic expression of CEH significantly improved glucose tolerance 
and insulin sensitivity in LDLR-/- mice (Bie et al, 2010) demonstrating a critical role for CE 
mobilization in the development of insulin resistance and Type-2 diabetes mellitus (T2DM). 
Chronic low grade inflammation is increasingly being recognized as a key step in the 
pathogenesis of obesity-induced insulin resistance and T2DM and expanding adipose tissue 
was initially recognized as the site of production of pro-inflammatory mediators (Trayhurn 
and Wood 2004, Weiss 2004) responsible for this low grade inflammation. However, recent 
studies have demonstrated that majority of adipose tissue derived cytokines (TNF, IL-6 
and IL-1) actually originate in non-fat cells and among them, infiltrated macrophages play 
the most prominent role. This low-grade inflammation is mediated by the activation and 
recruitment of macrophages into the expanding adipose tissue (Bouloumié et al 2005). The 
level of macrophages within a tissue represents a balance between recruitment, 
survival/expansion and emigration which is facilitated by several chemokines and growth 
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factors produced by adipocytes as well as infiltrated resident macrophages. These include 
monocyte chemoattracttant protein 1 (MCP-1) (Kanda et al, 2006), macrophage colony 
stimulating factor (M-CSF) and granulocyte-macrophage colony stimulating factor (GM-
CSF) (Kim et al, 2008) that recruit and assist in expansion or colonization of macrophages, 
respectively. Whether accumulation of cholesterol in macrophages can affect macrophage 
recruitment into the adipose tissue due to increased production of these pro-inflammatory 
mediators has not been explored. Subramanian et al have recently reported that addition of 
relatively small amount (0.15%) of dietary cholesterol resulted in marked increase in 
accumulation of macrophages in adipose tissue (Subramanian et al, 2008). Although this 
study provides the first evidence that cholesterol plays an important role in macrophage 
infiltration into the adipose tissue, the role of macrophage cholesterol balance in regulating 
this process remains undefined. We demonstrated that CEH-mediated increase in CE 
mobilization in macrophages decreased activation of pro-inflammatory transcription factor 
NF-B resulting in decreased expression of pro-inflammatory chemokines (e.g., MCP-1) and 
cytokines (e.g., IL-1 and IL-6) resulting in significant reduction in circulating cytokines. 
Macrophage infiltration into expanding adipose tissue was also significantly reduced in 
CEH transgenic mice. Further, insulin signaling in adipocytes was not dramatically 
perturbed by CEH over-expressing macrophages (Bie et al, 2010). Collectively, these data led 
us to propose the following model (Figure 5) whereby CEH-mediated reduction in 
macrophage CE levels regulate infiltration of macrophages into the expanding adipose 
tissue. Reduction in the number of macrophages limits the deleterious effects of 
macrophage-adipocyte interactions that are central to the development of insulin resistance. 
 
 
Fig. 5. Proposed model for Improved Insulin Sensitivity by CEH-mediated macrophage CE 
mobilization 
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Besides hypercholesterolemia, chronic low grade inflammation, obesity and T2DM are 
additional risk factors for development of atherosclerosis and CAD. Our data showing CEH-
mediated attenuation of insulin resistance and systemic as well as adipose tissue 
inflammation establishes macrophage CE mobilization as an important therapeutic target 
that can simultaneously affect multiple and linked metabolic disease processes. 
2.5.2 CEH-mediated CE mobilization and hepatic steatosis 
In addition to the development of obesity and insulin resistance, both of which are risk 
factors for atherosclerosis, excessive intake of high calorie or high fat food also leads to the 
ectopic deposition of excess fat in tissues other than the physiological fat depots such as 
adipose tissue. Increased accumulation of lipids in liver results in hepatic steatosis that is 
central to the development of non-alcoholic fatty liver disease and which progresses into 
non-alcoholic steatohepatitis. The etiology of this disease is distinct from a similar liver 
pathology seen with alcoholism and hence the name.  
Upon excessive lipid storage liver overproduces multiple cardiovascular risk factors such as 
glucose, very low density lipoproteins, plasminogen activator inhibitor-1 (PAI-1) 
coagulation factors and C-reactive protein (CRP). In addition, liver fat content is closely 
related to fasting insulin concentrations and direct measures of hepatic insulin sensitivity 
and increase in hepatic lipid contents predicts T2DM (Yki-Jarvinen, 2005). The mechanism(s) 
responsible for increased intra-hepatic triglyceride accumulation are not completely 
understood. It has been suggested that dysfunctional adipose tissue, characterized by 
adipocyte hypertrophy, macrophage infiltration, impaired insulin signaling, and insulin 
resistance, releases a host of inflammatory adipokines and excessive amounts of free fatty 
acids (FFA) that promote ectopic fat deposition in liver (Cusi, 2010). Alterations in FFA 
uptake regulated at the level of fatty acid transporter, CD36 expression is thought to be 
involved in increased triglyceride accumulation and hepatic CD36 expression is directly 
correlated with liver fat in human subjects (Greco et al, 2008).  
Kupffer cells are resident macrophages present in the liver and, therefore, changes in 
macrophage metabolism and/or phenotype will also affect kupffer cells. However, the role 
of hepatocyte microenvironment namely the effect of Kupffer cells in regulating triglyceride 
accumulation in hepatocytes is not completely defined. Pro-inflammatory cytokines 
(namely, IL-1┚, IL-6 or TNF┙) secreted by Kupffer cells activate hepatocytes (Scott et al, 
2005), affect gluconeogenesis (Yerkovich et al, 2004), increase the expression of acute phase 
proteins (Knolle et al, 1995) and enzymes involved in xenobiotic metabolism (Milosevic et al, 
1999). On the other hand, anti-inflammatory cytokine IL-10 secreted by Kupffer cells is 
essential for hepatocyte homeostasis and its loss under conditions of Kupffer cell depletion 
is associated with increased STAT3-dependent signalling and steatosis leading to decreased 
insulin signalling (Clementi et al, 2009). These studies underscore the importance of 
understanding the mechanisms involved in regulating the inflammatory status of Kupffer 
cells. To directly evaluate the role of kupffer cells, we examined hepatocyte triglyceride (TG) 
accumulation in livers of leptin-deficient obese (ob/ob) mice that were crossed with 
macrophage-specific CEH transgenic mice. Leptin deficiency in these ob/ob mice leads to 
increased obesity resulting in significant ectopic lipid accumulation in the liver and, thus, 
providing an ideal model to test the effects of decreased CE accumulation in kupffer cells as 
a result of transgenic expression of CEH on hepatocyte TG metabolism. Accumulated lipids 
are stored as cytoplsamic lipid droplets that continue to occupy greater cellular area and 
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total area occupied by lipid was used as a measure of total lipid accumulation and percent 
area occupied by lipid was significantly reduced by transgenic expression of CEH (Table 1). 
These data were confirmed by direct quantification of TG in total hepatic lipids where a 
significant decrease in hepatic TG content was observed in ob/ob-CEH transgenic mice. It is 
important to note that expression of CEH transgene in this model is macrophages-specific 
and, therefore, the observed effects are due to the changes in kupffer cell CE metabolism. 
 
Gentotype Percent area occupied by lipid Total TG (g/mg tissue) 
ob/ob 45.4 ± 5.3 32.3 ± 4.3 
ob/ob-CEH 
Transgenic 
39.5 ± 3.1** 23.1 ± 4.2** 
Table 1. Macrophage-specific transgenic expression of significantly decreases hepatic lipid 
accumulation **P<0.05 
Consistent with a reduction in hepatic lipid content, ob/ob-CEH transgenic mice showed 
improved glucose tolerance and insulin sensitivity.  
Macrophage polarization plays a pivotal role in the development of insulin resistance and 
it is promoted by a transition from an alternative M2 activation state maintained by 
STAT6 and PPARs to a classical M1 activation state driven by NF-B, AP1, and other 
signal-dependent transcription factors that play crucial roles in innate immunity (Olefsky 
and Glass, 2010). While IL-1┚, IL-6 and TNF┙ are the predominant cytokines secreted by 
M1 macrophages, M2 macrophages secrete anti-inflammatory cytokines IL-10 and IL-13. 
M1 activation by LPS via Toll-like receptor 4 (TLR4) or by free fatty acids as identified 
recently, triggers inflammatory responses (Bilan et al, 2009). Intracellular lipid content, 
specifically the cholesterol content, is increasingly being recognized as another major 
factor that contributes to macrophage activation. While cholesterol loading of 
macrophages activated TLR4 (Sun et al, 2009), HDL or ApoA1-mimetic stimulated 
removal of cellular cholesterol abolished LPS-induced mRNA expression of pro-
inflammatory mediators such as MCP-1, MIP-1, RANTES, IL-6, and TNF-alpha but 
significantly up-regulated LPS-induced anti-inflammatory IL-10 expression (Smythies et 
al, 2010). Interaction of ApoA1 with cholesterol transporter ABCA1, suppressed the ability 
of LPS to induce pro-inflammatory cytokine expression suggesting that cholesterol 
removal from macrophages is an anti-inflammatory event (Tang et al, 2009). CEH-
mediated increase in CE mobilization and subsequent decrease in cellular cholesterol 
content is, therefore, likely to polarize the macrophages to an M2 or anti-inflammatory 
phenotype. This is consistent with our earlier data demonstrating a decrease in expression 
of pro-inflammatory cytokines via reduced activation of NF-B and AP-1 in CEH 
transgenic macrophages (Bie et al, 2010) that leads to a decrease in the levels of pro-
inflammatory cytokines (e.g., IL-6) in circulation and reduction in systemic inflammation. 
Based on these data, we propose the following model (Figure 6) to integrate the cellular 
events and interactions that lead to the increased accumulation of TG in the liver and how 
CEH-mediated reduction in cellular CE content resulting in M2 polarization of Kupffer 
cells as well as decrease in circulating cytokines such as IL-6 can attenuate this process. 
The studies described above and the recent developments linking cellular CE content to 
macrophage phenotype and inflammation underscore the importance of macrophage 
cholesterol homeostasis in regulating multiple metabolic disorders. 
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Fig. 6. Proposed model by which CEH-mediated macrophage CE mobilization attenuates 
hepatic TG accumulation and improves insulin sensitivity. 
2.5.3 CEH-mediated CE mobilization and atherosclerotic plaque stability 
In recent years, there has been a shift in the paradigm of arterial re-modelling during 
progression of atherosclerosis and improved understanding of the mechanism underlying 
acute coronary syndromes or sudden heart attacks. The earlier notion of gradual narrowing 
of the arterial lumen that eventually occludes the coronary artery resulting in heart attacks is 
being replaced by the concept of a developing plaque in the arterial wall (that may or may 
not affect the lumen) that becomes unstable and prone to rupture. Thrombotic events 
resulting from the sudden release of lipid contents of the plaque into circulation is now 
considered as the primary cause of acute coronary events. Large necrotic cores as well as 
increased inflammation associated with plaques are the two main factors that determine 
plaque stability. 
Macrophage content of plaque is variable during the development of plaques (from fatty 
streaks to complex plaques) and is determined by processes involved in macrophage 
recruitment, apoptosis and egress. A balance between these processes limits plaque 
progression and is also likely to maintain favourable plaque characteristics. With increased 
lipid accumulation, plaque-associated foam cells undergo apoptosis and functional 
macrophages are required for efficient clearance of apoptotic cells (or efferocytosis). Inability 
to effectively clear the apoptotic cells results in accumulation of released lipids and other 
inflammatory mediators that lead to secondary necrosis. Growth of acellular necrotic core 
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not only destabilizes the plaque by altering its physical characteristics, but it also limits 
smooth muscle cell proliferation required to maintain the integrity of the fibrous cap of the 
plaque. Our earlier studies have demonstrated a decrease in lesion necrosis in macrophage-
specific CEH transgenic mice. These lesions also contained increased number of 
macrophages and significantly less number of apoptotic cells (Zhao et al, 2007). Collectively, 
these characteristics are suggestive of a more stable plaque. 
Khallou-Laschet et al evaluated the phenotype of macrophages associated with progression 
of atherosclerosis in mice and demonstrated that early lesions were infiltrated with 
alternatively activated and anti-inflammatory M2 macrophages which favoured smooth cell 
proliferation and deposition of extra-cellular matrix (tissue repair phenotype). However, a 
phenotypic switch of existing macrophages within the plaques from M2 to M1 (classically 
activated macrophages with pro-inflammatory properties) occurred during plaque 
progression resulting in increased inflammation (Khallou-Laschet et al, 2010). M1 
macrophages, identified by high expression of Ly6C surface antigen (Ly6CHi), increase with 
hypercholesterolemia, actively adhere to endothelium, become lesional macrophages and 
represent a newly recognized component of the inflammatory response in atherosclerosis 
(Swirski et al, 2007). We examined the phenotype of diet-induced lesion associated 
macrophages isolated from LDLR-/- and LDLR-/-CEH transgenic mice. Consistent with our 
earlier results described above, increased polarization towards M2 phenotype was noted in 
lesional macrophages from CEH transgenic mice. Studies are in progress to determine the 
effects of CEH-mediated shift in macrophage polarization on lesion-associated 
inflammation. 
Increase in inflammation with increasing cellular cholesterol content has been known for a 
long time. Recent studies have also shown that deficiency of cholesterol transporter ABCA1 
in LDLR-/- mice that results in massive CE accumulation, leads to an exacerbated response 
to lipopolysaccharide and increased inflammation (Francone et al, 2005). Increased 
inflammatory gene expression was also noted in macrophages from ABCG1 deficient 
macrophages (Balden et al, 2008). However, cellular mechanisms that directly link changes 
in cellular cholesterol homeostasis to inflammatory pathways remain undefined. In cells 
with increased CE accumulation, we demonstrated that CEH-mediated CE mobilization 
directly attenuated NF-B and AP1-driven gene expression suggesting that pro-
inflammatory transcription factor-driven gene expression is directly affected by cellular CE 
content (Bie et al 2010). However, the intracellular processes that are involved in “sensing” 
and “linking” of cellular CE content to inflammatory gene expression still remain to be 
elucidated.  
3. Conclusions 
Maintaining macrophage cholesterol homeostasis is central to atherogenesis. While 
unregulated uptake of modified LDL results in increased cellular CE content and foam cell 
formation, CEH-mediated mobilization of CE represent an important mechanism by which 
macrophages reduce the lipid burden. Given the importance of this step, intracellular CE 
hydrolysis is a multi-enzyme process and several enzymes catalyze this reaction. It is 
extremely important that the future focus is maintained on intracellular CE hydrolysis and 
not on establishing the “major” CE hydrolase in either human or mouse macrophages. 
Current strategies of single gene ablation are likely to be inconclusive not only due to the 
presence of multiple enzymes but also due to as yet unrecognized compensatory 
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mechanisms that may become operative under conditions of single gene deficiency leading 
to erroneous dismissal of the candidate CE hydrolase as unimportant . 
Removal of cholesterol from arterial wall associated macrophage foam cells represents the 
first step in prevention of atherosclerotic plaque formation or regression of existing plaques. 
Our results with CEH over-expression conclusively demonstrate the anti-atherogenic role of 
this enzyme in mobilizing stored CE from macrophages and attenuating atherogenesis. 
Cholesterol removed from the periphery including artery wall associated macrophages is 
returned to the liver via HDL and liver is the only organ that facilitates final elimination of 
cholesterol from the body. Since 80% of the total cholesterol delivered by HDL is CE, hepatic 
hydrolysis of CE is crucial to further metabolism of cholesterol. Consistently, increase in 
hepatic CE hydrolysis enhances elimination of cholesterol as bile acids in faeces. More 
importantly, increasing CE hydrolysis in liver alone stimulates movement of cholesterol 
from macrophages to faeces. Thus, hydrolysis of CE is an extremely important step in 
removal of cholesterol from the body and intracellular CE hydrolysis represents an 
important anti-atherogenic step that should be targeted for therapeutic benefit.  
Although macrophage cholesterol homeostasis is intuitively linked to atherogenesis as the 
primary disease process, continuing characterization of macrophage-specific CEH 
transgenic mice has revealed novel roles of CEH in regulating several disease processes and 
has established the central role of macrophage cholesterol homeostasis. By modulating 
infiltration of macrophages into adipose tissue and thus affecting adipose tissue as well as 
systemic inflammation, mobilization of CE from macrophages improves glucose tolerance 
and insulin sensitivity. Similarly, by altering the polarization towards a more anti-
inflammatory phenotype, increased CE mobilization from kupffer cells attenuates hepatic 
steatosis. Altered polarization towards M2 phenotype in atherosclerotic lesions also leads to 
decreased lesion necrosis and increased macrophage survival. Collectively, these studies 
clearly establish CEH as an important therapeutic target with a potential to simultaneously 
affect multiple disease processes. Ongoing studies will establish the direct link(s) between 
cellular CE content and inflammatory pathways and identify the intracellular pathways 
involved. 
From a clinical and translational perspective, future studies are necessary to delineate 
endogenous mechanisms that regulate these CE hydrolases such that these can be 
specifically targeted (e.g., by pharmacological means) to increase the activity in vivo.  
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